120 related articles for article (PubMed ID: 31731183)
1. Generation of two compound heterozygous HGSNAT-mutated lines from healthy induced pluripotent stem cells using CRISPR/Cas9 to model Sanfilippo C syndrome.
Benetó N; Cozar M; García-Morant M; Creus-Bachiller E; Vilageliu L; Grinberg D; Canals I
Stem Cell Res; 2019 Dec; 41():101616. PubMed ID: 31731183
[No Abstract] [Full Text] [Related]
2. Generation of two NAGLU-mutated homozygous cell lines from healthy induced pluripotent stem cells using CRISPR/Cas9 to model Sanfilippo B syndrome.
Benetó N; Cozar M; Gort L; Pacheco L; Vilageliu L; Grinberg D; Canals I
Stem Cell Res; 2020 Jan; 42():101668. PubMed ID: 31825816
[No Abstract] [Full Text] [Related]
3. Generation of human induced pluripotent stem cell line carrying SCN5AC2204>T Brugada mutation (MUSli009-A-1) introduced by CRISPR/Cas9-mediated genome editing.
Angsutararux P; Luanpitpong S; Chingsuwanrote P; Supraditaporn K; Waeteekul S; Terbto P; Lorthongpanich C; Laowtammathron C; U-Pratya Y; Issaragrisil S
Stem Cell Res; 2019 Dec; 41():101618. PubMed ID: 31677524
[TBL] [Abstract][Full Text] [Related]
4. Generation of a WWTR1 mutation induced pluripotent stem cell line, MUSIi012-A-1, using CRISPR/Cas9.
Lorthongpanich C; Jiamvoraphong N; Supakun P; Damkham N; Terbto P; Waeteekul S; U-Pratya Y; Laowtammathron C; Issaragrisil S
Stem Cell Res; 2019 Dec; 41():101634. PubMed ID: 31677525
[TBL] [Abstract][Full Text] [Related]
5. Generation of NERCe003-A-3, a p53 compound heterozygous mutation human embryonic stem cell line, by CRISPR/Cas9 editing.
Li Y; Huang C; Zha L; Kong M; Yang Q; Zhu Y; Peng Y; Ouyang Q; Lu G; Lin G; Zhou D
Stem Cell Res; 2019 Jan; 34():101371. PubMed ID: 30658254
[TBL] [Abstract][Full Text] [Related]
6. Generation of human embryonic stem cell line with heterozygous RB1 deletion by CRIPSR/Cas9 nickase.
Tu J; Huo Z; Liu M; Wang D; Xu A; Zhou R; Zhu D; Gingold J; Shen J; Zhao R; Lee DF
Stem Cell Res; 2018 Apr; 28():29-32. PubMed ID: 29414415
[TBL] [Abstract][Full Text] [Related]
7. Functional analysis of the HGSNAT gene in patients with mucopolysaccharidosis IIIC (Sanfilippo C Syndrome).
Fedele AO; Hopwood JJ
Hum Mutat; 2010 Jul; 31(7):E1574-86. PubMed ID: 20583299
[TBL] [Abstract][Full Text] [Related]
8. Generation of a homozygous CRISPR/Cas9-mediated knockout human iPSC line for the STUB1 locus.
Schuster S; Saravanakumar S; Schöls L; Hauser S
Stem Cell Res; 2019 Jan; 34():101378. PubMed ID: 30605842
[TBL] [Abstract][Full Text] [Related]
9. Generation of two iPSC lines with either a heterozygous V717I or a heterozygous KM670/671NL mutation in the APP gene.
Frederiksen HR; Holst B; Ramakrishna S; Muddashetty R; Schmid B; Freude K
Stem Cell Res; 2019 Jan; 34():101368. PubMed ID: 30634129
[TBL] [Abstract][Full Text] [Related]
10. Sanfilippo syndrome type C: mutation spectrum in the heparan sulfate acetyl-CoA: alpha-glucosaminide N-acetyltransferase (HGSNAT) gene.
Feldhammer M; Durand S; Mrázová L; Boucher RM; Laframboise R; Steinfeld R; Wraith JE; Michelakakis H; van Diggelen OP; Hrebícek M; Kmoch S; Pshezhetsky AV
Hum Mutat; 2009 Jun; 30(6):918-25. PubMed ID: 19479962
[TBL] [Abstract][Full Text] [Related]
11. Generation of an OCT4 reporter human induced pluripotent stem cell line using CRISPR/SpCas9.
Balboa D; Weltner J; Novik Y; Eurola S; Wartiovaara K; Otonkoski T
Stem Cell Res; 2017 Aug; 23():105-108. PubMed ID: 28925359
[TBL] [Abstract][Full Text] [Related]
12. Creating a patient carried Men1 gene point mutation on wild type iPSCs locus mediated by CRISPR/Cas9 and ssODN.
Guo D; Liu H; Gao G; Liu Y; Zhuang Y; Yang F; Wang K; Zhou T; Qin D; Hong L; Li J; Xu K; Li YX
Stem Cell Res; 2017 Jan; 18():67-69. PubMed ID: 28395809
[TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas9 Genome Editing: A Promising Tool for Therapeutic Applications of Induced Pluripotent Stem Cells.
Zhang Y; Sastre D; Wang F
Curr Stem Cell Res Ther; 2018; 13(4):243-251. PubMed ID: 29446747
[TBL] [Abstract][Full Text] [Related]
14. Generation of two ERF gene knockout human embryonic stem cell lines using CRISPR/Cas9 system.
Si L; Yang R; Liu J; Dong Y; Zhang H; Xu X
Stem Cell Res; 2019 Dec; 41():101644. PubMed ID: 31743839
[TBL] [Abstract][Full Text] [Related]
15. Generation of a PDX1-EGFP reporter human induced pluripotent stem cell line, KSCBi005-A-3, using the CRISPR/Cas9 system.
Lee Y; Choi HY; Kwon A; Park H; Park MH; Kim JW; Kim MJ; Kim YO; Kwak S; Koo SK
Stem Cell Res; 2019 Dec; 41():101632. PubMed ID: 31683099
[TBL] [Abstract][Full Text] [Related]
16. A genetic and clinical study of individuals with nonsyndromic retinopathy consequent upon sequence variants in HGSNAT, the gene associated with Sanfilippo C mucopolysaccharidosis.
Schiff ER; Daich Varela M; Robson AG; Pierpoint K; Ba-Abbad R; Nutan S; Zein WM; Ullah E; Huryn LA; Tuupanen S; Mahroo OA; Michaelides M; Burke D; Harvey K; Arno G; Hufnagel RB; Webster AR
Am J Med Genet C Semin Med Genet; 2020 Sep; 184(3):631-643. PubMed ID: 32770643
[TBL] [Abstract][Full Text] [Related]
17. Generation of two heterozygous GATA2 CRISPR/Cas9-edited iPSC lines, R398W and R396Q, for modeling GATA2 deficiency.
Castaño J; Romero-Moya D; Richaud-Patin Y; Giorgetti A
Stem Cell Res; 2021 Aug; 55():102445. PubMed ID: 34284273
[TBL] [Abstract][Full Text] [Related]
18. Generation of a gene-corrected isogenic iPSC line (AHQUi001-A-1) from a patient with familial hypertriglyceridemia (FHTG) carrying a heterozygous p.C310R (c.928 T > C) mutation in LPL gene using CRISPR/Cas9.
Sun X; Zhou X; Dong B; Wang C; Xiao X; Wang Y
Stem Cell Res; 2021 Apr; 52():102230. PubMed ID: 33592566
[TBL] [Abstract][Full Text] [Related]
19. Mutational analysis of the HGSNAT gene in Italian patients with mucopolysaccharidosis IIIC (Sanfilippo C syndrome). Mutation in brief #959. Online.
Fedele AO; Filocamo M; Di Rocco M; Sersale G; Lübke T; di Natale P; Cosma MP; Ballabio A
Hum Mutat; 2007 May; 28(5):523. PubMed ID: 17397050
[TBL] [Abstract][Full Text] [Related]
20. Generation and validation of PAX7 reporter lines from human iPS cells using CRISPR/Cas9 technology.
Wu J; Hunt SD; Xue H; Liu Y; Darabi R
Stem Cell Res; 2016 Mar; 16(2):220-8. PubMed ID: 26826926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
